David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

Among the biggest losers in Wednesday’s early trading are Allscripts (Nasdaq: MDRX), Nokia (NYSE: NOK) and CVS Caremark (NYSE: CVS). Top Percentage Losers — Wednesday, June 9, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Loss 52-Week High 52-Week Low Allscripts (Nasdaq: MDRX) $16.78 -8.9% $22.55… Read More

Among the biggest winners in Tuesday’s early trading are Durect (Nasdaq: DRRX), A123 Systems (Nasdaq: AONE) and Gammon Gold (NYSE: GRS). Top Percentage Gainers — Tuesday, June 8, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Gain 52-Week High 52-Week Low Durect (Nasdaq: DRRX) $2.62 +8.3%… Read More

Among the biggest losers in Monday’s early trading are Delcath (NYSE: DCTH), CVS Caremark (NYSE: CVS) and Coldwater Creek (Nasdaq: CWTR). Top Percentage Losers — Monday, June 7, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Loss 52-Week High 52-Week Low Delcath (Nasdaq: DCTH) $12.80 -12.6% $16.45 $2.71… Read More

What a week. The market gyrations are likely triggering strong demand for heartburn medicine right now. Stocks of all stripes took it on the chin, and many are now down for the year. Whiles investors focused on the daunting headlines, they may have overlooked some important news coming out of… Read More